ImmuPharma plc

Stocks

IMM

GB0033711010

Delayed London S.E. 01:06:08 06/10/2026 pm IST			5-day change	1st Jan Change
3.795 ^GBX	+15.88%		+16.59%	-38.79%

24/09	WINNERS & LOSERS: Quantum Data restored; Asos upbeat on outlook	AN
18/09	WINNERS & LOSERS: Mothercare review; Dianomi agrees acquisition	AN

Transcript : ImmuPharma plc - Shareholder/Analyst Call

Published on 03/25/2026 at 09:38 pm IST - Modified on 03/28/2026 at 05:53 am IST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good afternoon, ladies and gentlemen, and welcome to the ImmuPharma plc corporate update. [Operator Instructions] Due to the significant attendance on

This article is reserved for our subscribers.

Subcribe
to read the article

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

Latest news about ImmuPharma plc

24/09	WINNERS & LOSERS: Quantum Data restored; Asos upbeat on outlook	AN
18/09	WINNERS & LOSERS: Mothercare review; Dianomi agrees acquisition	AN
16/09	EARNINGS AND TRADING: Amcomri revenue up; Unicorn Namibia acquisition	AN
15/09	ImmuPharma plc Reports Earnings Results for the Half Year Ended June 30, 2026	CI
15/09	ImmuPharma Files International Patent Application for P140 Immunormalizer	MT
15/09	Immupharma Publishes Peer-Reviewed Research Reporting P140 Activity In Preclinical MASH Model	CI
15/09	Immupharma PLC Files International Patent Cooperation Treaty Application For P140 Precision Medicine Approach In Autoimmune Disease	CI
17/08	WINNERS & LOSERS: Time Finance backs buyout; Nostrum sells assets	AN
10/08	Fulcrum amends Terra option; Galantas expands drilling	AN
10/08	ImmuPharma Enlists Kymos as CRO Partner for Kapiglucagon Program	MT
06/08	WINNERS & LOSERS: Devolver Digital to delist; Wellnex sells business	AN
30/07	WINNERS & LOSERS: Vanquis cuts outlook; Zoo Digital loss narrows	AN
29/07	WINNERS & LOSERS: Mobico raises outlook; Hargreaves Services profit up	AN
23/07	Technology Minerals announces leadership changes	AN
22/07	ImmuPharma Hires Drug Product, Contract Development, Manufacturing Partner for Diabetes Program	MT

Chart ImmuPharma plc

Duration

Period

IMM: Dynamic Chart

Company Profile

Sector

More about the company

Income Statement and Estimates

More financial data